Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary dapsone-resistant leprosy in Cebu, Philippines

R S Guinto, R V Cellona, T T Fajardo

    International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association
    |December 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.

    Human vaccines·2011
    Same author

    Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.

    Human vaccines·2011
    Same author

    Rise of attack in leprosy in relation to age at exposure.

    The American journal of tropical medicine and hygiene·2010
    Same author

    Mycobacterium leprae in untreated lepromatous leprosy: more than skin deep.

    Clinical and experimental dermatology·2006
    Same author

    Serial measurement of serum cytokines, cytokine receptors and neopterin in leprosy patients with reversal reactions.

    Leprosy review·2004
    Same author

    Prospective study of serological conversion as a risk factor for development of leprosy among household contacts.

    Clinical and diagnostic laboratory immunology·2004

    A study in Cebu, Philippines, found primary dapsone-resistant leprosy in 3.6% of cases. Most Mycobacterium leprae strains remained susceptible to dapsone, but two showed resistance in mouse models.

    Area of Science:

    • Medical Microbiology
    • Tropical Medicine
    • Epidemiology

    Background:

    • Leprosy remains a significant public health concern globally.
    • Dapsone has been the cornerstone of multidrug therapy for leprosy.
    • Emergence of drug resistance can compromise treatment efficacy and disease control.

    Purpose of the Study:

    • To determine the prevalence of primary dapsone resistance in leprosy patients in Cebu, Philippines.
    • To characterize the susceptibility of Mycobacterium leprae isolates to dapsone.

    Main Methods:

    • A survey was conducted to identify leprosy patients in Cebu.
    • Susceptibility testing was performed using mouse models inoculated with Mycobacterium leprae isolates.
    • Minimal effective dose and a 10-fold higher dose of dapsone were administered to mice.

    Related Experiment Videos

    Main Results:

    • The prevalence of primary dapsone-resistant leprosy was estimated at 3.6 per 100 patients.
    • Out of 55 patients, 53 had Mycobacterium leprae fully susceptible to dapsone.
    • Mycobacterium leprae from two patients multiplied in mice receiving the minimal effective dapsone dose; one isolate also multiplied at a 10-fold higher dose.

    Conclusions:

    • Primary dapsone resistance in leprosy exists in Cebu, Philippines, at a notable prevalence.
    • While most isolates remain susceptible, the identification of resistant strains necessitates ongoing surveillance.
    • Further research is needed to understand the mechanisms and implications of dapsone resistance in leprosy.